Skip to main content
Journal cover image

Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines.

Publication ,  Journal Article
Wiercioch, W; Nieuwlaat, R; Dahm, P; Iorio, A; Mustafa, RA; Neumann, I; Rochwerg, B; Manja, V; Alonso-Coello, P; Ortel, TL; Santesso, N ...
Published in: J Clin Epidemiol
October 2021

OBJECTIVE: Stakeholders involved in developing recommendations need to have a common understanding of health outcomes and the perspective of affected individuals. In this paper we report on the development and application of health outcome descriptors (HODs) to inform decision-making by panels developing guideline recommendations. STUDY DESIGN AND SETTING: Ten American Society of Hematology guideline panels addressing the management of venous thromboembolism developed HODs, rated their importance and health utility, applied them to prioritize outcomes, and to balance potential benefits and harms to formulate recommendations. RESULTS: It was feasible to involve 18 panelists in developing 127 HODs. There was high agreement (82%) across the ten panels about outcomes perceived as critical or important for decision-making. Panelists' utility ratings of the outcomes were strongly correlated with panelists' outcome importance ratings (Pearson's r=-0.88). HODs were incorporated into Grading of Recommendations Assessment, Development and Evaluation (GRADE) evidence-to-decision (EtD) frameworks to support a shared understanding of health outcomes in panel deliberations. CONCLUSION: HODs serve as a valuable tool to promote an explicit, common understanding of health outcomes during clinical guideline development and across different stakeholders. They are helpful across multiple steps of guideline development to facilitate panels' judgements, aiming to avoid variable implicit interpretations of health outcomes.

Duke Scholars

Published In

J Clin Epidemiol

DOI

EISSN

1878-5921

Publication Date

October 2021

Volume

138

Start / End Page

115 / 127

Location

United States

Related Subject Headings

  • Venous Thromboembolism
  • United States
  • Practice Guidelines as Topic
  • Outcome Assessment, Health Care
  • Humans
  • Fibrinolytic Agents
  • Evidence-Based Medicine
  • Epidemiology
  • Clinical Decision-Making
  • 4202 Epidemiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wiercioch, W., Nieuwlaat, R., Dahm, P., Iorio, A., Mustafa, R. A., Neumann, I., … ASH VTE Panels Working Group. (2021). Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines. J Clin Epidemiol, 138, 115–127. https://doi.org/10.1016/j.jclinepi.2021.04.016
Wiercioch, Wojtek, Robby Nieuwlaat, Philipp Dahm, Alfonso Iorio, Reem A. Mustafa, Ignacio Neumann, Bram Rochwerg, et al. “Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines.J Clin Epidemiol 138 (October 2021): 115–27. https://doi.org/10.1016/j.jclinepi.2021.04.016.
Wiercioch W, Nieuwlaat R, Dahm P, Iorio A, Mustafa RA, Neumann I, et al. Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines. J Clin Epidemiol. 2021 Oct;138:115–27.
Wiercioch, Wojtek, et al. “Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines.J Clin Epidemiol, vol. 138, Oct. 2021, pp. 115–27. Pubmed, doi:10.1016/j.jclinepi.2021.04.016.
Wiercioch W, Nieuwlaat R, Dahm P, Iorio A, Mustafa RA, Neumann I, Rochwerg B, Manja V, Alonso-Coello P, Ortel TL, Santesso N, Vesely SK, Akl EA, Schünemann HJ, ASH VTE Panels Working Group. Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines. J Clin Epidemiol. 2021 Oct;138:115–127.
Journal cover image

Published In

J Clin Epidemiol

DOI

EISSN

1878-5921

Publication Date

October 2021

Volume

138

Start / End Page

115 / 127

Location

United States

Related Subject Headings

  • Venous Thromboembolism
  • United States
  • Practice Guidelines as Topic
  • Outcome Assessment, Health Care
  • Humans
  • Fibrinolytic Agents
  • Evidence-Based Medicine
  • Epidemiology
  • Clinical Decision-Making
  • 4202 Epidemiology